Jazz Pharmaceuticals
JAZZ
#1882
Rank
A$14.03 B
Marketcap
$231.11
Share price
0.18%
Change (1 day)
15.79%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.00

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.27. In 2022 the company made an earnings per share (EPS) of -$5.70 an increase over its 2021 EPS that were of -$8.66.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.00-64.84%
2022-$5.70-34.2%
2021-$8.66-224.83%
2020$6.94-53.25%
2019$14.8523.59%
2018$12.01-8.24%
2017$13.0923.74%
2016$10.5822.12%
2015$8.66478.49%
2014$1.50-74.93%
2013$5.97-27.11%
2012$8.2069.1%
2011$4.85245.98%
2010$1.40-462.5%
2009-$0.39-96.7%
2008-$11.72-27.04%
2007-$16.0765.47%
2006-$9.71-4.59%
2005-$10.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.47 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$13.35-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.02-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.22 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel